Sabal Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $26.6M | Sell |
295,873
-885
| -0.3% | -$82.6K | 1.47% | 29 |
|
|
2024
Q4 | $29.5M | Sell |
296,758
-84,658
| -22% | -$8.73M | 1.71% | 16 |
|
|
2024
Q3 | $43.3M | Sell |
381,416
-7,480
| -2% | -$889K | 2.36% | 7 |
|
|
2024
Q2 | $48.1M | Sell |
388,896
-9,862
| -2% | -$1.27M | 2.87% | 4 |
|
|
2024
Q1 | $52.6M | Sell |
398,758
-8,900
| -2% | -$1.1M | 3.06% | 2 |
|
|
2023
Q4 | $44.4M | Sell |
407,658
-16,308
| -4% | -$1.69M | 2.73% | 3 |
|
|
2023
Q3 | $43.6M | Sell |
423,966
-5,610
| -1% | -$605K | 2.92% | 2 |
|
|
2023
Q2 | $49.6M | Buy |
429,576
+6,554
| +2% | +$744K | 3.15% | 2 |
|
|
2023
Q1 | $45M | Sell |
423,022
-10,077
| -2% | -$1.09M | 3.14% | 2 |
|
|
2022
Q4 | $48.1M | Sell |
433,099
-9,799
| -2% | -$1M | 3.27% | 1 |
|
|
2022
Q3 | $38.1M | Buy |
442,898
+1,577
| +0.4% | +$141K | 2.88% | 5 |
|
|
2022
Q2 | $40.2M | Buy |
441,321
+3,183
| +0.7% | +$282K | 2.89% | 4 |
|
|
2022
Q1 | $35.9M | Buy |
438,138
+10,221
| +2% | +$806K | 2.49% | 11 |
|
|
2021
Q4 | $32.8M | Buy |
427,917
+15,326
| +4% | +$1.22M | 2.08% | 18 |
|
|
2021
Q3 | $31M | Buy |
412,591
+22,718
| +6% | +$1.73M | 2.22% | 17 |
|
|
2021
Q2 | $30.3M | Sell |
389,873
-6,987
| -2% | -$520K | 2.19% | 19 |
|
|
2021
Q1 | $29.2M | Buy |
396,860
+19,772
| +5% | +$1.46M | 2.17% | 18 |
|
|
2020
Q4 | $29.4M | Buy |
377,088
+6,208
| +2% | +$475K | 2.37% | 14 |
|
|
2020
Q3 | $29.4M | Sell |
370,880
-10,499
| -3% | -$822K | 2.56% | 13 |
|
|
2020
Q2 | $28.1M | Sell |
381,379
-7,416
| -2% | -$558K | 2.63% | 13 |
|
|
2020
Q1 | $28.5M | Sell |
388,795
-13,907
| -3% | -$1.09M | 3.21% | 7 |
|
|
2019
Q4 | $34.9M | Buy |
402,702
+3,103
| +0.8% | +$255K | 2.77% | 5 |
|
|
2019
Q3 | $32.1M | Buy |
399,599
+1,893
| +0.5% | +$152K | 2.59% | 13 |
|
|
2019
Q2 | $31.8M | Buy |
397,706
+8,270
| +2% | +$633K | 2.8% | 7 |
|
|
2019
Q1 | $30.9M | Sell |
389,436
-12,827
| -3% | -$959K | 2.75% | 7 |
|
|
2018
Q4 | $29.3M | Sell |
402,263
-21,981
| -5% | -$1.55M | 3.01% | 4 |
|
|
2018
Q3 | $28.7M | Buy |
424,244
+12,091
| +3% | +$770K | 2.54% | 11 |
|
|
2018
Q2 | $23.9M | Buy |
412,153
+399,199
| +3,082% | +$22.5M | 2.27% | 23 |
|
|
2018
Q1 | $674K | Buy |
12,954
+4,832
| +59% | +$261K | 0.06% | 85 |
|
|
2017
Q4 | $436K | Buy |
8,122
+998
| +14% | +$55.3K | 0.04% | 93 |
|
|
2017
Q3 | $435K | Sell |
7,124
-90
| -1% | -$5.46K | 0.04% | 95 |
|
|
2017
Q2 | $441K | Sell |
7,214
-5,535
| -43% | -$337K | 0.05% | 88 |
|
|
2017
Q1 | $773K | Buy |
12,749
+5,535
| +77% | +$336K | 0.09% | 63 |
|
|
2016
Q4 | $405K | Sell |
7,214
-998
| -12% | -$58.4K | 0.04% | 86 |
|
|
2016
Q3 | $488K | Sell |
8,212
-401,412
| -98% | -$23.5M | 0.05% | 81 |
|
|
2016
Q2 | $22.5M | Buy |
409,624
+15,912
| +4% | +$847K | 2.6% | 25 |
|
|
2016
Q1 | $19.9M | Buy |
393,712
+16,635
| +4% | +$815K | 2.36% | 27 |
|
|
2015
Q4 | $19M | Buy |
377,077
+369,047
| +4,596% | +$18.6M | 2.48% | 25 |
|
|
2015
Q3 | $379K | Sell |
8,030
-222
| -3% | -$11.8K | 0.05% | 77 |
|
|
2015
Q2 | $448K | Buy |
8,252
+718
| +10% | +$40.3K | 0.06% | 76 |
|
|
2015
Q1 | $413K | Sell |
7,534
-210
| -3% | -$11.9K | 0.05% | 80 |
|
|
2014
Q4 | $419K | Sell |
7,744
-52
| -0.7% | -$2.9K | 0.05% | 81 |
|
|
2014
Q3 | $441K | Sell |
7,796
-494
| -6% | -$27.7K | 0.06% | 74 |
|
|
2014
Q2 | $458K | Buy |
8,290
+730
| +10% | +$39.8K | 0.07% | 71 |
|
|
2014
Q1 | $409K | Sell |
7,560
-47
| -0.6% | -$2.43K | 0.06% | 72 |
|
|
2013
Q4 | $364K | Sell |
7,607
-726
| -9% | -$33.2K | 0.05% | 80 |
|
|
2013
Q3 | $379K | Sell |
8,333
-314
| -4% | -$14.3K | 0.06% | 75 |
|
|
2013
Q2 | $383K | Buy |
+8,647
| New | +$386K | 0.06% | 75 |
|
Other funds holding MRK
Sabal Trust's MRK Position: Q1 2025 in Review
Sabal Trust reduced its Merck (MRK) stake by 0.3% in Q1 2025, selling an estimated $82.6K and leaving 295,873 shares worth $26.6M. The position accounts for 1.47% of the portfolio, ranked #29.
Sabal Trust first reported a position in MRK in Q2 2013 and has held it in 48 quarters since. The position peaked at $52.6M in Q1 2024. 3,448 funds tracked by Wall St. Rank hold MRK as of Q1 2025.
- Sabal Trust held 295,873 shares of Merck worth $26.6M as of Q1 2025.
- Sabal Trust sold 885 Merck shares in Q1 2025, an estimated $82.6K.
- Merck made up 1.47% of Sabal Trust's portfolio in Q1 2025, its #29 holding.
- Sabal Trust first reported a position in Merck in Q2 2013 and has held it in 48 quarters since.
- Sabal Trust's Merck position peaked at $52.6M in Q1 2024.
- 3,448 funds tracked by Wall St. Rank held Merck as of Q1 2025.
Based on Sabal Trust's 13F filing for Q1 2025, filed 23 Apr 2025.